Journals / Medicine Science / 2015 / Cilt: 4 - Sayı: 1

Andrographis Paniculata (Burm. F.) Nees Induces Clinical and Sputum Conversion in Pulmonary Tuberculosis Patients

Pages
1869–1875
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

F.) Nees was to accelerate the beneficial therapeutic effect of TB chemotherapy by improving clinical and sputum response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to determine whether Andrographus paniculata capsule induces clinical and sputum conversion in pulmonary tuberculosis (TB) patients.
📊
Key Findings & Data:A total of 44 pulmonary TB patients were randomly divided into two groups including one group received standard antituberculosis drugs + Andrographis paniculata (n=21) (AP) and one group received standard antituberculosis drugs + placebo (n=23).
💡
Conclusion & Impact:F.) Nees was to accelerate the beneficial therapeutic effect of TB chemotherapy by improving clinical and sputum response.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to determine whether Andrographus paniculata capsule induces clinical and sputum conversion in pulmonary tuberculosis (TB) patients. Randomized, placebo-controlled, double-blind pilot study was conducted to pulmonary tuberculosis patient who admitted to Pulmonology Polyclinic of Persahabatan Central General Hospital, Jakarta. A total of 44 pulmonary TB patients were randomly divided into two groups including one group received standard antituberculosis drugs + Andrographis paniculata (n=21) (AP) and one group received standard antituberculosis drugs + placebo (n=23). APC was given 500 milligram per day for eight weeks. The distribution of sex, body weight and body mass index (BMI) as well as the frequency of cough and feature of chest radiography were not significantly different between groups (P >0.05). The proportion of posiıtive smears in both groups decreased over time until by the twelve weeks, none remained positive. The rate of decline was more pronounced in the AP group reach statistically at weeks 4 and 6 compared to placebo group (P<0.05). Adjunctive supplementation of Andrographis paniculata (Burm. F.) Nees was to accelerate the beneficial therapeutic effect of TB chemotherapy by improving clinical and sputum response.

🔖

Cite This Article

WİDHAWATİ, R., HANANİ, E., ZAİNİ, J. (2015). Andrographis Paniculata (Burm. F.) Nees Induces Clinical and Sputum Conversion in Pulmonary Tuberculosis Patients. Medicine Science, Cilt: 4 - Sayı: 1, 1869–1875. https://ajindex.com/articles/277726

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Palma C, Vendetti S, Cassone A. Role of 4-1BB Receptor in the control played by CD8+ T cells on IFN-c production by Mycobacterium tuberculosis antigen-specific CD4+ T cells. PLoS ONE. 2010;5(6): e11019
  2. Zuniga J, Torres-Garcia D, Santos-Mendoza T, Rodriquez-Reyna TS, Granados J, Yunis EJ. Cellular and humoral mechanisms invoved in the control of tuberculosis. Clin Dev Immunol. 2012;2012:193923
  3. Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Frontiers in Biosci. 2004;9:975-94
  4. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603-62
  5. Karyadi E, West CE, Schultink W, Nelwan WH, Gross R, Amin Z, Dolmans WMV, Schlebush H, van der Meer JWM. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr. 2002;75(4):720-7
  6. Flynn J, Chan J. Immunology of tuberculosis. Ann Rev Immunol. 2001;19:93-129
  7. Boussiotis VA, Tsai EY, Yumis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A. Rousset D, Reynes JM, Goldfeld AE. IL-10 producing T cells suppress immune response in anergic tuberculosis patients. J Clin Invest. 2000;105(9):1317-25
  8. Geffner L, Yokobori N, Basile J, Schierloh P, Balboa L, Romero MM, Ritacco V. Vescovo M, Montaner PG, Lopez B, Barrera L, Aleman M, Abatte E, Sasiain MC, de la Barrera S. Patients with multidrug tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun. 2009;77:5025-34
  9. Karyadi E, Dolmans WM, West CE, Van Crevel R, Nelwan RH, Amin Z, Gross R, van der ven Jongekrijg, van der Meer JWM. Cytokines related to nutritional status in patients with untreated pulmonary tuberculosis in Indonesia. Asia Pac J Clin Nutr. 2007;16(2):218-26
  10. Panossian A, Davtyan T, Gukassyan N, Gukasova G, Mamikonyan G, Gabrielian E, Wikman G. Effect of andrographolide and Kan Jang fixed combination of extract SHA-10 and extract SHE-3 on proliferation of human lymphocytes, production of cytokines and immune activa